Calimmune was founded in 2006 based on breakthrough gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies).
Calimmune is accelerating the promise of gene therapy to liberate patients from chronic and currently incurable diseases. To achieve our ambitious goal, we have built a suite of technologies to advance the delivery, manufacturing, and overall efficiency of these life-changing medicines. Calimmune's lead development programs are novel ex-vivo gene therapies for hematologic diseases.
We are privileged to have some of the world’s most respected gene therapy developers, clinicians, scientific advisors and commercialization experts committed to our mission. We are passionate about what we do, and for those we ultimately seek to serve.
Company Details
- Founded
- -
- Phone
- (619) 849-5375
- ma****@****omm.com
- Industry
- Biotechnology
- Website
- calimmune.com
Calimmune, Inc. (Purchased By Csl Behring) Questions
Calimmune, Inc. (Purchased By Csl Behring)'s helpline number is (619) 849-5375
Calimmune, Inc. (Purchased By Csl Behring)'s website is calimmune.com
Calimmune, Inc. (Purchased By Csl Behring)'s LinkedIn profile is https://www.linkedin.com/company/calimmune-inc
Calimmune, Inc. (Purchased By Csl Behring)'s industry is
Biotechnology
Calimmune, Inc. (Purchased By Csl Behring)'s top competitors are
Fonds De Dotation Csl Behring Pour La Recherche,
Xeris Pharmaceuticals, Inc.,
Cytokinetics,
Takeda,
Csl Behring España S.a.,
Rampart Bioscience,
Telix Pharmaceuticals Limited,
Thermo Fisher Scientific,
Csl,
Csl Behring Com. De Produtos Farmac̻uticos Ltda..
Calimmune, Inc. (Purchased By Csl Behring)'s support email address is mark@canalecomm.com
Calimmune, Inc. (Purchased By Csl Behring)'s categories are Biotechnology
Calimmune, Inc. (Purchased By Csl Behring)'s founding year is 2006
